The effect of commonly used drugs on angiogenesis

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 231-234

  Sartippour, Maryam R ^a   De Leon, Ernesto ^a   Rubio, Rosalio ^a   Brooks, Mai N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Atenolol; Cimetidine; Coumadin; Diltiazem; Disopyramide; Enalapril; Endothelium; Mexiletine; Omeprazole

Indexed keywords

ATENOLOL; CIMETIDINE; DILTIAZEM; DISOPYRAMIDE; ENALAPRIL; MEXILETINE; OMEPRAZOLE; WARFARIN;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG USE; ENDOTHELIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ATENOLOL; CELL DIVISION; CELLS, CULTURED; CIMETIDINE; DILTIAZEM; DISOPYRAMIDE; DRUG EVALUATION, PRECLINICAL; ENALAPRIL; ENDOTHELIUM, VASCULAR; HUMANS; MEXILETINE; OMEPRAZOLE; PILOT PROJECTS; WARFARIN;

EID: 0037231390     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 27-31, 1995.
2. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-63, 1995.
3. Weidner N, Semple JP, Welch WR and Fölkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
4. Weidner N and Folkman J: Tumoral vascularity as a prognostic factor in cancer. Imp Adv Oncol 167-90, 1996.
5. Nguyen M, Watanabe H, Budson A, Richie J, Hayes D and Folkman J: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356-61, 1994.
6. Marshall JL and Hawkins MJ: The clinical experience with antiangiogenic agents. Breast Cancer Res Treatm 36: 253-61, 1995.
7. Gradishar WJ: An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action. Invest New Drugs 15: 49-59, 1997.
8. Masiero L, Figg WD and Kohn EC: New anti-angiogenesis agents: Review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12. Angiogenesis 1: 23-35, 1997.
9. Pluda JM: Tumor-associated angiogenesis: Mechanisms, clinical implications, and therapeutic strategies. Sem Oncol 24: 203-18, 1997.
10. Sartippour MR, Heber D, Liu Y, Ma J, Lu Q, Go VL and Nguyen M: Green tea and its catechin components inhibit breast cancer xenografts. Nutr Cancer 40: 149-156, 2001.
11. Gagliardi A and Collins DC: Inhibition of angiogenesis by antiestrogens. Cancer Res 53: 533-35, 1993.
12. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R and Taraboletti G: The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Can Res 2: 1843-9, 1996.
13. Danesi R, Agen C, Benelli U, Di Paolo A, Nardini D, Bocci G, Basolo F, Campagni A and Del Tacca M: Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clin Can Res 3: 265-72, 1997.
14. Liaudet-Coopman EDE, Berchem GJ and Wellstein A: In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma. Clin Cancer Res 3: 179-84, 1997.
15. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ and Bouck NP: Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 98: 671-9, 1996.
16. Moses MA, Sudhalter J and Langer R: Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408-10, 1990.
17. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R and Schweigerer L: Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57: 2916-21, 1997.